Protein degradation rate is the dominant mechanism accounting for the differences in protein abundance of basal p53 in a human breast and colorectal cancer cell line

• Eszter Lakatos ,

  Contributed equally to this work with: Eszter Lakatos, Ali Salehi-Reyhani, Michael Barclay

  ¶‡ These authors are co-first authors on this work.

  Affiliation Department of Life Sciences, Centre for Integrative Systems Biology and Bioinformatics, Imperial College London, London, United Kingdom

  ⨯
• Ali Salehi-Reyhani ,

  Contributed equally to this work with: Eszter Lakatos, Ali Salehi-Reyhani, Michael Barclay

  * E-mail: ali.salehi-reyhani@imperial.ac.uk

  ¶‡ These authors are co-first authors on this work.

  Affiliation Department of Chemistry, Institute of Chemical Biology, Imperial College London, London, United Kingdom

  http://orcid.org/0000-0002-1084-2012

  ⨯
• Michael Barclay ,

  Contributed equally to this work with: Eszter Lakatos, Ali Salehi-Reyhani, Michael Barclay

  ¶‡ These authors are co-first authors on this work.

  Affiliation Department of Chemistry, Institute of Chemical Biology, Imperial College London, London, United Kingdom

  ⨯
• Michael P. H. Stumpf,

  Affiliation Department of Life Sciences, Centre for Integrative Systems Biology and Bioinformatics, Imperial College London, London, United Kingdom

  ⨯
• David R. Klug

  Affiliation Department of Chemistry, Institute of Chemical Biology, Imperial College London, London, United Kingdom

  ⨯